Thus, employing an original design, a novel dual-ligand small molecule concurrently targeting HDAC enzymes and σ1R was synthesized and subjected to functional characterization with respect to the proliferation and spreading of melanoma cells and endothelial-dependent angiogenic processes. Here, HDAC9 is linked to melanoma.